FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Dr. rer. nat. Friedrich Hahn
List of publications:
BibTeX-Download
Institute of Clinical and Molecular Virology
Professur für Virologie
Publications
(36)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
IMU-838, a small molecule DHODH inhibitor in phase II clinical trial for multiple sclerosis, shows potent Anti-EBV activity in cell-culture-based systems: Potential additional benefits in multiple sclerosis treatment (2021)
Marschall M, Peelen E, Müller R, Wangen C, Wagner S, Muehler A, Groeppel M, et al.
Conference contribution
A placental specific miRNA miR-517a-3p exerts anti-human cytomegalovirus activity (2021)
Hamilton ST, Hahn F, Sonntag E, Marschall M, Rawlinson WD
Journal article
Methodological development of a multi-readout assay for the assessment of antiviral drugs against sars-cov-2 (2021)
Hahn F, Häge S, Herrmann A, Wangen C, Kicuntod J, Jungnickl D, Tillmanns J, et al.
Journal article
Properties of Oligomeric Interaction of the Cytomegalovirus Core Nuclear Egress Complex (NEC) and Its Sensitivity to an NEC Inhibitory Small Molecule (2021)
Kicuntod J, Alkhashrom S, Häge S, Diewald B, Müller R, Hahn F, Lischka P, et al.
Journal article
Combinatorial drug treatments reveal promising anticytomegaloviral profiles for clinically relevant pharmaceutical kinase inhibitors (PKIs) (2021)
Wild M, Kicuntod J, Seyler L, Wangen C, Bertzbach LD, Conradie AM, Kaufer BB, et al.
Journal article
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro (2020)
Hahn F, Wangen C, Häge S, Peter AS, Dobler G, Hurst B, Julander J, et al.
Journal article
The Artemisinin-Derived Autofluorescent Compound BG95 Exerts Strong Anticytomegaloviral Activity Based on a Mitochondrial Targeting Mechanism (2020)
Wild M, Hahn F, Grau B, Herrmann L, Niesar A, Schütz M, Lorion MM, et al.
Journal article
Target verification of artesunate-related antiviral drugs: Assessing the role of mitochondrial and regulatory proteins by click chemistry and fluorescence labeling (2020)
Hahn F, Niesar A, Wangen C, Wild M, Grau B, Herrmann L, Capci A, et al.
Journal article
Mass spectrometry-based characterization of the virion proteome, phosphoproteome, and associated kinase activity of human cytomegalovirus (2020)
Couté Y, Kraut A, Zimmermann C, Büscher N, Hesse AM, Bruley C, De Andrea M, et al.
Journal article, Review article
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice (2020)
Wild M, Bertzbach LD, Tannig P, Wangen C, Müller R, Herrmann L, Fröhlich T, et al.
Journal article
‹
1
2
3
4
›